Astaxanthin supplementation assists sorafenib in slowing skeletal muscle atrophy in H22 tumsor-bearing mice via reversing abnormal glucose metabolism.

Our findings show the significant potential of Astaxanthin as nutritional supplements for cancer patients, as well as the notion that nutritional interventions should be implemented at the initiation of cancer treatment, as instead of waiting until cachexia sets in. This article is protected by copyright. All rights reserved.